Solicitation of Nominations for Appointment to the Advisory Committee on Immunization Practices, 58378-58379 [2024-15792]
Download as PDF
khammond on DSKJM1Z7X2PROD with NOTICES
58378
Federal Register / Vol. 89, No. 138 / Thursday, July 18, 2024 / Notices
NIOSH–232, by either of the methods
listed below. CDC does not accept
comments by email.
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Ms. Sherri Diana, NIOSH
Docket Office, National Institute for
Occupational Safety and Health, 1090
Tusculum Avenue, Mailstop C–34,
Cincinnati, Ohio 45226. Attn: Docket
No. CDC–2024–0055; NIOSH–232.
Instructions: All submissions received
must include the Agency name and
docket number. Docket number CDC–
2024–0055; NIOSH–232 will close
August 15, 2024.
FOR FURTHER INFORMATION CONTACT:
Kandyce Reeves, M.P.H., Designated
Federal Officer, Board of Scientific
Counselors, National Institute for
Occupational Safety and Health,
National Firefighter Registry
Subcommittee, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop V24–4, Atlanta,
Georgia 30329–4027. Telephone: (404)
498–1650; Email: KReeves3@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Secretary of Health
and Human Services, the Assistant
Secretary for Health, and by delegation,
the Director, Centers for Disease Control
and Prevention (CDC), are authorized
under Sections 301 and 308 of the
Public Health Service Act to conduct
directly, or by grants or contracts,
research, experiments, and
demonstrations relating to occupational
safety and health and to mine health.
The Board of Scientific Counselors,
National Institute for Occupational
Safety and Health (BSC, NIOSH)
provides advice to the NIOSH Director
on NIOSH research and prevention
programs. The Board also provides
guidance on the Institute’s research
activities related to developing and
evaluating hypotheses, systematically
documenting findings, and
disseminating results. In addition, the
Board evaluates the degree to which the
activities of NIOSH: (1) conform to those
standards of scientific excellence
appropriate for Federal scientific
institutions in accomplishing objectives
in occupational safety and health; (2)
address currently relevant needs in the
fields of occupational safety and health
either alone or in conjunction with
other known activities inside and
outside of NIOSH; and (3) produce their
intended results in addressing
important research questions in
occupational safety and health, both in
terms of applicability of the research
findings and dissemination of the
findings.
VerDate Sep<11>2014
16:47 Jul 17, 2024
Jkt 262001
Purpose: The BSC, NIOSH National
Firefighter Registry Subcommittee
provides scientific expertise to the
Board that assists the BSC, NIOSH in
advising the NIOSH Director about the
Institute’s efforts to establish and
operate the National Firefighter Registry
for Cancer. Specifically, the
Subcommittee advises the Board on the
following issues pertaining to the
‘‘required strategy’’ as mandated by the
Firefighter Cancer Registry Act of 2018
(the Act): (1) increase awareness of the
National Firefighter Registry for Cancer
and encourage participation among all
groups of firefighters; (2) consider data
collection needs; (3) consider data
storage and electronic access of health
information; and (4) in consultation
with subject matter experts, develop a
method for estimating the number and
type of fire incidents attended by a
firefighter. Additional responsibilities of
the Subcommittee are to provide
guidance to the Board regarding the
inclusion and maintenance of data on
firefighters as required by the Act.
Matters to be Considered: The agenda
for the meeting includes the National
Firefighter Registry for Cancer project
overview, status, national launch
updates, communication strategies,
targeted enrollment approach, data
review, and future planning applicable
to stakeholders. Agenda items are
subject to change as priorities dictate.
The agenda is also posted on the
NIOSH website at https://www.cdc.gov/
niosh/scientific-counselors/nfrs.html.
Written Public Comment: Written
comments will be accepted per the
instructions provided in the addresses
section above. Comments received in
advance of the meeting are part of the
public record and are subject to public
disclosure. The comments will be
included in the official record of the
meeting. Do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near-duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
Frm 00052
Fmt 4703
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–15794 Filed 7–17–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Public Participation
PO 00000
Written comments received by August
15, 2024, will be provided to the
Subcommittee prior to the meeting.
Oral Public Comment: The public is
welcome to participate during the
public comment period, from 11:45 a.m.
to 12 p.m., EDT, August 22, 2024. Each
commenter will be provided up to five
minutes for comment. A limited number
of time slots are available and will be
assigned on a first-come, first-served
basis. Members of the public who wish
to address the Subcommittee are
requested to contact the Designated
Federal Officer for scheduling purposes
(see FOR FUTHER INFORMATION CONTACT
above).
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sfmt 4703
Solicitation of Nominations for
Appointment to the Advisory
Committee on Immunization Practices
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), within the
Department of Health and Human
Services (HHS) is seeking nominations
for membership on the Advisory
Committee on Immunization Practices
(ACIP). The ACIP consists of up to 19
experts in fields associated with
immunization practices and public
health, use of vaccines and other
immunobiological agents in clinical
practice or preventive medicine, clinical
or laboratory vaccine research,
assessment of vaccine efficacy and
safety, or have knowledge about
SUMMARY:
E:\FR\FM\18JYN1.SGM
18JYN1
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 138 / Thursday, July 18, 2024 / Notices
consumer perspectives and/or social
and community aspects of
immunization programs.
DATES: Nominations for membership on
the ACIP must be received no later than
August 15, 2024. Packages received after
this time will not be considered for the
current membership cycle.
ADDRESSES: All nominations must be
completed online at https://
www.cdc.gov/vaccines/acip/apply-formembership/.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, Committee
Management Specialist, Advisory
Committee on Immunization Practices,
National Center for Immunization and
Respiratory Diseases, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, Mailstop H24–8,
Atlanta, Georgia 30329–4027.
Telephone: (404) 639–8836; Email:
ACIP@cdc.gov.
SUPPLEMENTARY INFORMATION: The
Advisory Committee on Immunization
Practices (ACIP) is charged with
advising the Director, Centers for
Disease Control and Prevention (CDC),
on the use of immunizing agents. In
addition, under 42 U.S.C. 1396s, the
Committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for
administration to vaccine-eligible
children through the Vaccines for
Children program, along with schedules
regarding dosing interval, dosage, and
contraindications to administration of
vaccines. Further, under applicable
provisions of the Affordable Care Act
and section 2713 of the Public Health
Service Act and implementing
regulations, immunization
recommendations of ACIP that have
been approved by the Director, CDC,
and appear on CDC immunization
schedules generally must be covered by
applicable health plans.
Nominations are being sought for
individuals who have the expertise and
qualifications necessary to contribute to
the accomplishments of the committee’s
objectives. Nominees will be selected
based on expertise in the fields of
immunization practices, multidisciplinary expertise in public health,
expertise in the use of vaccines and
immunologic agents in both clinical and
preventive medicine, knowledge of
vaccine development, evaluation, and
vaccine delivery, or knowledge about
consumer perspectives and/or social
and community aspects of
immunization programs. Federal
employees will not be considered for
membership. Members may be invited
to serve for up to four-year terms.
Selection of members is based on
VerDate Sep<11>2014
16:47 Jul 17, 2024
Jkt 262001
candidates’ qualifications to contribute
to the accomplishment of ACIP
objectives (https://www.cdc.gov/
vaccines/acip/).
HHS policy stipulates that committee
membership be balanced in terms of
points of view represented, and the
committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens
and cannot be full-time employees of
the U.S. Government. Current
participation on Federal workgroups or
prior experience serving on a Federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees, requiring the filing of
financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for ACIP membership each year and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in July 2025, or as
soon as the HHS selection process is
completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year. SGE nominees must be
U.S. citizens and cannot be full-time
employees of the U.S. Government.
Candidates should submit the following
items:
■ Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address)
■ Two letters of recommendation
from professional colleagues familiar
with the candidate’s work. A maximum
of four letters of recommendation will
be accepted.
Æ Letters of recommendation should
not come from current ACIP members.
Æ At least one letter of
recommendation from person(s) not
employed by HHS. Candidates may
submit letter(s) from current HHS
employees if they wish, but at least one
letter must be submitted by a person not
employed by an HHS agency (e.g.,
National Institutes of Health, Food and
Drug Administration, Substance Abuse
and Mental Health Services
Administration, etc.). CDC employees
should not provide letters of
recommendation.
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
58379
■ A cover letter that includes the
candidate’s statement of interest in
serving on the ACIP, the qualifications
and expertise that the candidate would
bring, and written evidence to support
how the candidate meets all relevant
criteria.
Nominations may be submitted by the
candidate or by the person/organization
recommending the candidate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–15792 Filed 7–17–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting of the Advisory Board on
Radiation and Worker Health, National
Institute for Occupational Safety and
Health
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting of the Advisory
Board on Radiation and Worker Health
(ABRWH or the Advisory Board). This
is a virtual meeting. It is open to the
public, with a public comment period.
The public is also welcome to submit
written comments in advance of the
meeting, to the contact person listed in
the addresses section below. The public
is also welcome to listen to the meeting
by joining the teleconference
(information below), limited only by the
number of audio conference lines
available (150).
DATES: The meeting will be held on
August 7, 2024, from 11 a.m. to 6 p.m.,
EDT, and on August 8, 2024, from 11
a.m. to 1 p.m., EDT. A public comment
session will be held on August 7, 2024,
SUMMARY:
E:\FR\FM\18JYN1.SGM
18JYN1
Agencies
[Federal Register Volume 89, Number 138 (Thursday, July 18, 2024)]
[Notices]
[Pages 58378-58379]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-15792]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Advisory
Committee on Immunization Practices
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC), within the Department
of Health and Human Services (HHS) is seeking nominations for
membership on the Advisory Committee on Immunization Practices (ACIP).
The ACIP consists of up to 19 experts in fields associated with
immunization practices and public health, use of vaccines and other
immunobiological agents in clinical practice or preventive medicine,
clinical or laboratory vaccine research, assessment of vaccine efficacy
and safety, or have knowledge about
[[Page 58379]]
consumer perspectives and/or social and community aspects of
immunization programs.
DATES: Nominations for membership on the ACIP must be received no later
than August 15, 2024. Packages received after this time will not be
considered for the current membership cycle.
ADDRESSES: All nominations must be completed online at https://www.cdc.gov/vaccines/acip/apply-for-membership/.
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, Committee Management
Specialist, Advisory Committee on Immunization Practices, National
Center for Immunization and Respiratory Diseases, Centers for Disease
Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8, Atlanta,
Georgia 30329-4027. Telephone: (404) 639-8836; Email: [email protected].
SUPPLEMENTARY INFORMATION: The Advisory Committee on Immunization
Practices (ACIP) is charged with advising the Director, Centers for
Disease Control and Prevention (CDC), on the use of immunizing agents.
In addition, under 42 U.S.C. 1396s, the Committee is mandated to
establish and periodically review and, as appropriate, revise the list
of vaccines for administration to vaccine-eligible children through the
Vaccines for Children program, along with schedules regarding dosing
interval, dosage, and contraindications to administration of vaccines.
Further, under applicable provisions of the Affordable Care Act and
section 2713 of the Public Health Service Act and implementing
regulations, immunization recommendations of ACIP that have been
approved by the Director, CDC, and appear on CDC immunization schedules
generally must be covered by applicable health plans.
Nominations are being sought for individuals who have the expertise
and qualifications necessary to contribute to the accomplishments of
the committee's objectives. Nominees will be selected based on
expertise in the fields of immunization practices, multi-disciplinary
expertise in public health, expertise in the use of vaccines and
immunologic agents in both clinical and preventive medicine, knowledge
of vaccine development, evaluation, and vaccine delivery, or knowledge
about consumer perspectives and/or social and community aspects of
immunization programs. Federal employees will not be considered for
membership. Members may be invited to serve for up to four-year terms.
Selection of members is based on candidates' qualifications to
contribute to the accomplishment of ACIP objectives (https://www.cdc.gov/vaccines/acip/).
HHS policy stipulates that committee membership be balanced in
terms of points of view represented, and the committee's function.
Appointments shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, gender identity, HIV
status, disability, and cultural, religious, or socioeconomic status.
Nominees must be U.S. citizens and cannot be full-time employees of the
U.S. Government. Current participation on Federal workgroups or prior
experience serving on a Federal advisory committee does not disqualify
a candidate; however, HHS policy is to avoid excessive individual
service on advisory committees and multiple committee memberships.
Committee members are Special Government Employees, requiring the
filing of financial disclosure reports at the beginning and annually
during their terms. CDC reviews potential candidates for ACIP
membership each year and provides a slate of nominees for consideration
to the Secretary of HHS for final selection. HHS notifies selected
candidates of their appointment near the start of the term in July
2025, or as soon as the HHS selection process is completed. Note that
the need for different expertise varies from year to year and a
candidate who is not selected in one year may be reconsidered in a
subsequent year. SGE nominees must be U.S. citizens and cannot be full-
time employees of the U.S. Government. Candidates should submit the
following items:
[squf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address)
[squf] Two letters of recommendation from professional colleagues
familiar with the candidate's work. A maximum of four letters of
recommendation will be accepted.
[cir] Letters of recommendation should not come from current ACIP
members.
[cir] At least one letter of recommendation from person(s) not
employed by HHS. Candidates may submit letter(s) from current HHS
employees if they wish, but at least one letter must be submitted by a
person not employed by an HHS agency (e.g., National Institutes of
Health, Food and Drug Administration, Substance Abuse and Mental Health
Services Administration, etc.). CDC employees should not provide
letters of recommendation.
[squf] A cover letter that includes the candidate's statement of
interest in serving on the ACIP, the qualifications and expertise that
the candidate would bring, and written evidence to support how the
candidate meets all relevant criteria.
Nominations may be submitted by the candidate or by the person/
organization recommending the candidate.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-15792 Filed 7-17-24; 8:45 am]
BILLING CODE 4163-18-P